Arkolith/Insider Trading/ADGI/Form 4

Adimab, LLC

10% OwnerAdagio Therapeutics, Inc. (ADGI) · full profile →Form 4 · filed Aug 12, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
1 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 10, 2021Conversion(C)25.9M——27.8M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 10, 2021Conversion(C)44K—$00
Aug 10, 2021Conversion(C)5.0M—$00
Aug 10, 2021Conversion(C)128K—$00

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-051295) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML